Symbols / INTS $5.55 -1.86% Intensity Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
INTS Chart
About

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 14.10M
Enterprise Value 2.67M Income -11.61M Sales —
Book/sh 4.70 Cash/sh 4.69 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -1.39 PEG —
P/S — P/B 1.18 P/C —
EV/EBITDA — EV/Sales — Quick Ratio 5.55
Current Ratio 5.92 Debt/Eq 0.93 LT Debt/Eq —
EPS (ttm) -8.56 EPS next Y -4.00 EPS Growth —
Revenue Growth — Earnings 2025-11-06 16:00 ROA -79.25%
ROE -156.90% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 2.54M
Shs Float 2.36M Short Float 2.15% Short Ratio 0.61
Short Interest — 52W High 50.00 52W Low 4.62
Beta 4.23 Avg Volume 52.50K Volume 6.78K
Target Price $48.67 Recom Strong_buy Prev Close $5.66
Price $5.55 Change -1.86%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$48.67
Mean price target
2. Current target
$5.62
Latest analyst target
3. DCF / Fair value
$-36.20
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.62
Low
$12.00
High
$125.00
Mean
$48.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-08-20 main Benchmark Speculative Buy → Speculative Buy $2
2025-08-12 up Brookline Capital Hold → Buy $3
2025-01-13 init Alliance Global Partners — → Buy $9
2024-11-21 reit HC Wainwright & Co. Buy → Buy $5
2024-10-31 init HC Wainwright & Co. — → Buy $5
2024-07-11 reit Benchmark Speculative Buy → Speculative Buy $12
2024-05-16 reit Benchmark Speculative Buy → Speculative Buy $12
2024-03-21 reit Benchmark Speculative Buy → Speculative Buy $12
2023-11-14 reit Benchmark Speculative Buy → Speculative Buy $12
2023-08-24 reit Benchmark Speculative Buy → Speculative Buy $12
2023-07-18 init Benchmark — → Speculative Buy $12
News
RSS: Latest INTS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-31 TALAMO JOSEPH CPA Chief Financial Officer — 14,482 $0.41 $5,941
2025-12-31 WESOLOWSKI JOHN M CPA Officer — 8,918 $0.41 $3,658
2025-06-30 TALAMO JOSEPH CPA Chief Financial Officer — 14,179 $0.26 $3,701
2025-06-30 WESOLOWSKI JOHN M CPA Officer — 69,745 $0.26 $18,203
2024-06-05 WESOLOWSKI JOHN M CPA Officer — 1,000 $4.00 $4,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
11.97
-27.81%
16.59
+99.36%
8.32
+10.19%
7.55
Research And Development
6.79
-35.36%
10.50
+119.31%
4.79
-6.74%
5.13
Selling General And Administration
5.19
-14.81%
6.09
+72.35%
3.53
+46.11%
2.42
General And Administrative Expense
5.19
-14.81%
6.09
+72.35%
3.53
+46.11%
2.42
Salaries And Wages
2.64
-2.69%
2.72
+118.58%
1.24
+76.31%
0.70
Other Gand A
1.87
-25.02%
2.50
+48.51%
1.68
+2.69%
1.64
Total Expenses
11.97
-27.81%
16.59
+99.36%
8.32
+10.19%
7.55
Operating Income
-11.97
+27.81%
-16.59
-99.36%
-8.32
-10.19%
-7.55
Total Operating Income As Reported
-11.97
+27.81%
-16.59
-99.36%
-8.32
-10.19%
-7.55
EBITDA
-11.97
+27.81%
-16.59
-62.07%
-10.23
-36.44%
-7.50
Normalized EBITDA
-11.97
+27.81%
-16.59
-108.07%
-7.97
-6.28%
-7.50
EBIT
-11.97
+27.81%
-16.59
-62.07%
-10.23
-36.44%
-7.50
Total Unusual Items
—
0.00
+100.00%
-2.26
0.00
Total Unusual Items Excluding Goodwill
—
0.00
+100.00%
-2.26
0.00
Special Income Charges
—
0.00
+100.00%
-2.26
0.00
Other Special Charges
—
—
2.26
—
Net Income
-11.61
+28.66%
-16.27
-54.37%
-10.54
-38.99%
-7.58
Pretax Income
-11.61
+28.66%
-16.27
-54.37%
-10.54
-38.99%
-7.58
Net Non Operating Interest Income Expense
0.18
-42.68%
0.31
+1552.63%
0.02
+123.75%
-0.08
Interest Expense Non Operating
—
0.00
-100.00%
0.30
+271.95%
0.08
Net Interest Income
0.18
-42.68%
0.31
+1552.63%
0.02
+123.75%
-0.08
Interest Expense
—
0.00
-100.00%
0.30
+271.95%
0.08
Interest Income Non Operating
0.18
-42.68%
0.31
-3.09%
0.32
+16100.00%
0.00
Interest Income
0.18
-42.68%
0.31
-3.09%
0.32
+16100.00%
0.00
Other Income Expense
0.19
+6100.00%
0.00
+100.13%
-2.24
-4762.50%
0.05
Other Non Operating Income Expenses
0.19
+6100.00%
0.00
-87.50%
0.02
-50.00%
0.05
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-11.61
+28.66%
-16.27
-54.37%
-10.54
-38.99%
-7.58
Net Income From Continuing Operation Net Minority Interest
-11.61
+28.66%
-16.27
-54.37%
-10.54
-38.99%
-7.58
Net Income From Continuing And Discontinued Operation
-11.61
+28.66%
-16.27
-54.37%
-10.54
-38.99%
-7.58
Net Income Continuous Operations
-11.61
+28.66%
-16.27
-54.37%
-10.54
-38.99%
-7.58
Normalized Income
-11.61
+28.66%
-16.27
-96.57%
-8.28
-9.15%
-7.58
Net Income Common Stockholders
-11.61
+28.66%
-16.27
-37.14%
-11.86
-56.45%
-7.58
Diluted EPS
-8.56
+70.73%
-29.24
+15.25%
-34.50
+36.96%
-54.73
Basic EPS
-8.56
+70.73%
-29.24
+15.25%
-34.50
+36.96%
-54.73
Basic Average Shares
1.36
+143.83%
0.56
+61.40%
0.34
+148.77%
0.14
Diluted Average Shares
1.36
+143.83%
0.56
+61.40%
0.34
-34.22%
0.52
Diluted NI Availto Com Stockholders
-11.61
+28.66%
-16.27
-37.14%
-11.86
-56.45%
-7.58
Insurance And Claims
0.67
-23.34%
0.87
+43.75%
0.61
+710.67%
0.07
Preferred Stock Dividends
—
—
1.32
—
Rent And Landing Fees
—
—
—
0.14
Rent Expense Supplemental
—
—
—
0.14
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
14.10
+194.81%
4.78
-72.34%
17.30
+884.35%
1.76
Current Assets
12.71
+277.91%
3.36
-78.25%
15.46
+965.75%
1.45
Cash Cash Equivalents And Short Term Investments
11.92
+360.27%
2.59
-82.47%
14.78
+1026.22%
1.31
Cash And Cash Equivalents
11.92
+360.27%
2.59
-69.73%
8.56
+552.13%
1.31
Cash Equivalents
11.84
+447.41%
2.16
-73.60%
8.19
0.00
Cash Financial
0.09
-79.91%
0.43
+16.62%
0.37
-72.03%
1.31
Other Short Term Investments
—
0.00
-100.00%
6.22
0.00
Receivables
—
—
—
0.06
Taxes Receivable
—
—
—
0.02
Prepaid Assets
0.79
+1.94%
0.77
+12.35%
0.69
+992.06%
0.06
Other Current Assets
—
—
0.01
-92.11%
0.08
Total Non Current Assets
1.39
-1.97%
1.42
-22.45%
1.83
+498.37%
0.31
Net PPE
0.10
-21.31%
0.12
-17.01%
0.15
+5.76%
0.14
Gross PPE
0.10
-21.31%
0.12
-17.01%
0.15
+5.76%
0.14
Other Properties
0.10
-21.31%
0.12
-17.01%
0.15
+5.76%
0.14
Non Current Prepaid Assets
—
—
—
0.17
Other Non Current Assets
1.30
-0.15%
1.30
-22.92%
1.68
+908.38%
0.17
Total Liabilities Net Minority Interest
2.23
+19.30%
1.86
-54.88%
4.13
-75.48%
16.86
Current Liabilities
2.15
+22.28%
1.75
-55.67%
3.96
-41.94%
6.82
Payables And Accrued Expenses
1.31
-21.30%
1.67
-52.89%
3.55
+52.43%
2.33
Payables
0.58
-52.17%
1.22
-60.01%
3.05
+405.47%
0.60
Accounts Payable
0.58
-52.17%
1.22
-60.01%
3.05
+405.47%
0.60
Current Accrued Expenses
0.73
+61.95%
0.45
-9.42%
0.50
-71.06%
1.72
Pensionand Other Post Retirement Benefit Plans Current
0.80
+1328.57%
0.06
-85.71%
0.39
—
Current Debt And Capital Lease Obligation
0.03
+10.71%
0.03
+40.00%
0.02
-99.55%
4.49
Current Debt
—
—
—
4.35
Other Current Borrowings
—
—
—
4.35
Current Capital Lease Obligation
0.03
+10.71%
0.03
+40.00%
0.02
-86.01%
0.14
Total Non Current Liabilities Net Minority Interest
0.08
-28.18%
0.11
-36.78%
0.17
-98.27%
10.04
Long Term Debt And Capital Lease Obligation
0.08
-28.18%
0.11
-20.29%
0.14
0.00
Long Term Capital Lease Obligation
0.08
-28.18%
0.11
-20.29%
0.14
0.00
Other Non Current Liabilities
—
—
0.04
+0.00%
0.04
Preferred Securities Outside Stock Equity
—
—
0.00
-100.00%
10.00
Stockholders Equity
11.88
+306.99%
2.92
-77.83%
13.16
+187.18%
-15.10
Common Stock Equity
11.88
+306.99%
2.92
-77.83%
13.16
+187.18%
-15.10
Capital Stock
0.00
0.00
-100.00%
0.00
0.00
Common Stock
0.00
0.00
-100.00%
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
2.52
+317.33%
0.60
+10.31%
0.55
+4.66%
0.52
Ordinary Shares Number
2.52
+317.33%
0.60
+10.31%
0.55
+4.66%
0.52
Additional Paid In Capital
90.27
+29.50%
69.70
+9.46%
63.68
+170.33%
23.55
Retained Earnings
-78.39
-17.38%
-66.78
-32.20%
-50.52
-30.69%
-38.65
Total Equity Gross Minority Interest
11.88
+306.99%
2.92
-77.83%
13.16
+187.18%
-15.10
Total Capitalization
11.88
+306.99%
2.92
-77.83%
13.16
+187.18%
-15.10
Working Capital
10.56
+556.90%
1.61
-86.02%
11.51
+314.33%
-5.37
Invested Capital
11.88
+306.99%
2.92
-77.83%
13.16
+222.45%
-10.75
Total Debt
0.11
-20.29%
0.14
-12.66%
0.16
-96.48%
4.49
Net Debt
—
—
—
3.04
Capital Lease Obligations
0.11
-20.29%
0.14
-12.66%
0.16
+10.49%
0.14
Net Tangible Assets
11.88
+306.99%
2.92
-77.83%
13.16
+187.18%
-15.10
Tangible Book Value
11.88
+306.99%
2.92
-77.83%
13.16
+187.18%
-15.10
Duefrom Related Parties Current
—
—
—
0.05
Preferred Stock Equity
—
—
—
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-9.23
+39.34%
-15.22
-111.24%
-7.21
-31.55%
-5.48
Cash Flow From Continuing Operating Activities
-9.23
+39.34%
-15.22
-111.24%
-7.21
-31.55%
-5.48
Net Income From Continuing Operations
-11.61
+28.66%
-16.27
-54.37%
-10.54
-38.99%
-7.58
Other Non Cash Items
0.03
+144.83%
-0.06
-153.21%
0.11
-39.11%
0.18
Stock Based Compensation
2.00
-34.92%
3.07
+119.81%
1.40
+19.59%
1.17
Operating Gains Losses
—
—
2.26
—
Change In Working Capital
0.35
+117.64%
-1.97
-351.15%
-0.44
-157.60%
0.76
Change In Prepaid Assets
-0.01
-104.32%
0.30
+114.56%
-2.07
-4000.00%
0.05
Change In Payables And Accrued Expense
0.36
+115.87%
-2.27
-239.06%
1.63
+131.68%
0.70
Change In Accrued Expense
—
—
-0.20
0.00
Change In Payable
0.36
+115.87%
-2.27
-239.06%
1.63
+131.68%
0.70
Change In Account Payable
0.36
+115.87%
-2.27
-239.06%
1.63
+131.68%
0.70
Change In Other Current Assets
—
—
—
0.05
Change In Other Current Liabilities
—
—
—
-0.18
Investing Cash Flow
0.00
-100.00%
6.35
+205.50%
-6.02
0.00
Cash Flow From Continuing Investing Activities
0.00
-100.00%
6.35
+205.50%
-6.02
0.00
Net Investment Purchase And Sale
0.00
-100.00%
6.35
+205.50%
-6.02
0.00
Purchase Of Investment
0.00
+100.00%
-3.06
+79.70%
-15.05
0.00
Sale Of Investment
0.00
-100.00%
9.41
+4.21%
9.03
0.00
Financing Cash Flow
18.56
+540.14%
2.90
-85.83%
20.47
+809.87%
2.25
Cash Flow From Continuing Financing Activities
18.56
+540.14%
2.90
-85.83%
20.47
+809.87%
2.25
Net Issuance Payments Of Debt
—
0.00
-100.00%
0.23
-89.78%
2.25
Issuance Of Debt
—
0.00
-100.00%
0.23
-89.78%
2.25
Short Term Debt Issuance
—
0.00
-100.00%
0.23
-89.78%
2.25
Net Short Term Debt Issuance
—
0.00
-100.00%
0.23
-89.78%
2.25
Net Common Stock Issuance
20.32
+528.84%
3.23
-85.59%
22.43
0.00
Proceeds From Stock Option Exercised
0.06
-82.55%
0.32
+542.00%
0.05
0.00
Net Other Financing Charges
-1.82
-178.10%
-0.65
+70.76%
-2.23
—
Changes In Cash
9.33
+256.40%
-5.97
-182.36%
7.24
+324.48%
-3.23
Beginning Cash Position
2.59
-69.73%
8.56
+552.13%
1.31
-71.09%
4.54
End Cash Position
11.92
+360.27%
2.59
-69.73%
8.56
+552.13%
1.31
Free Cash Flow
-9.23
+39.34%
-15.22
-111.24%
-7.21
-31.55%
-5.48
Change In Interest Payable
—
—
-0.20
0.00
Common Stock Issuance
20.32
+528.84%
3.23
-85.59%
22.43
0.00
Issuance Of Capital Stock
20.32
+528.84%
3.23
-85.59%
22.43
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category